% Expired Patents = 20.0

CIPO Patents = 1

Forward Citations = 84

Loading Chart...

20 inventors (with patents filed for the assignee):

Stanley Chang (2 out of 2 patents)

Wen-Pin Chou (2 out of 8 patents)

Pei-Jer Chen (2 out of 5 patents)

4. Ping-Hei Chen (2 out of 3 patents)

5. Yi-Fan Hsieh (2 out of 2 patents)

6. Shiou-Hwei Yeh (2 out of 2 patents)

7. Kuan-Lang Lai (1 out of 1 patent)

8. Wan-Chen Chen (1 out of 3 patents)

9. Young-Sun Lin (1 out of 1 patent)

10. Kuei-Tai Lai (1 out of 2 patents)

11. Huei-Luen Huang (1 out of 1 patent)

12. Hsiang-Ting Hsu (1 out of 1 patent)

13. Ya-Lin Chen (1 out of 1 patent)

14. Chia-Wen Wong (1 out of 1 patent)

15. Hsun-Lang Chang (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 10842804 - Muparfostat for use in treating patients with hepatitis virus-related hepatocellular carcinoma after surgical resection (2020-11-24),

2. 9890206 - H1N1 flu virus neutralizing antibodies (2018-02-13),

3. 9126201 - Methods and apparatuses for convective polymerase chain reaction (PCR) (2015-09-08),

4. 8187813 - Methods and apparatuses for convective polymerase chain reaction (PCR) (2012-05-29),

5. 7507532 - Cancer specific gene MH15 (2009-03-24),

Company Overview

Medigen Biotechnology Corporation is a leading biotechnology company in Taiwan. They specialize in developing and manufacturing high-quality biopharmaceutical products, including vaccines, therapeutics, and diagnostics. With a strong focus on research and innovation, Medigen is dedicated to improving healthcare and advancing medical science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#778 in Taipei

#2,365 in Taiwan

Taipei, Taiwan

Medigen Biotechnology Corporation

Forward Citations = 84

20 inventors:

Stanley Chang (2 out of 2 patents)

Wen-Pin Chou (2 out of 8 patents)

Pei-Jer Chen (2 out of 5 patents)

4. Ping-Hei Chen (2 out of 3 patents)

5. Yi-Fan Hsieh (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medigen Biotechnology Corporation. Retrieved from https://idiyas.com/company/medigen-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]